AVM
Arch Venture Management Portfolio holdings
AUM
$299M
This Quarter Return
-14.48%
1 Year Return
-19.47%
3 Year Return
-31.35%
5 Year Return
–
10 Year Return
–
AUM
$91.4M
AUM Growth
+$91.4M
(-5.4%)
Cap. Flow
+$29.2M
Cap. Flow
% of AUM
31.96%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
1
Increased
–
Reduced
2
Closed
–
Top Buys
| 1 |
SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
|
$40M |
Top Sells
| 1 |
Kura Oncology
KURA
|
$6.83M |
| 2 |
Fate Therapeutics
FATE
|
$3.99M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SYRS
1
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $40M | 43.8% |
+3,855,051
| New | +$40M |
|
|
RUBY
2
DELISTED
Rubius Therapeutics, Inc
RUBY
| $20.6M | 22.5% |
2,618,351
| – | – |
|
|
3
Kura Oncology
KURA
$690M
| $13.7M | 15.05% |
906,307
-450,000
| -33% | -$6.83M |
|
|
4
Fate Therapeutics
FATE
$119M
| $11.1M | 12.18% |
716,392
-256,798
| -26% | -$3.99M |
|
|
CHMA
5
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $5.92M | 6.48% |
1,196,776
| – | – |
|